Latest stories

  • in

    Daily statin lowers cardiovascular disease risk in HIV+ people: Study

    Daily statin lowers cardiovascular disease risk in HIV+ people: Study

    Statins are a class of medicines routinely prescribed to lower cholesterol and are known to prevent cardiovascular disease in those at risk in the general population. A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living […] More

  • in

    Emcure, MSD get CDSCO Panel conditional nod to Manufacture, Market HIV drug Doravirine

    New Delhi: Citing the unmet need, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to drug major MSD for a Phase III clinical trial waiver involving the retroviral drugs Doravirine tablet 100mg and Doravirine bulk drug in support of Emcure Pharmaceuticals’ proposal for manufacturing and marketing […] More